82 results
Page 3 of 5
8-K
EX-10.1
nc8 l7ppxo2hm5c6
19 Jan 18
Relmada Therapeutics Acquires Global Rights to Develop and Market Dextromethadone for Treatment of Disorders of the Nervous System
12:00am
8-K
EX-10.2
2r120hd
19 Jan 18
Relmada Therapeutics Acquires Global Rights to Develop and Market Dextromethadone for Treatment of Disorders of the Nervous System
12:00am
8-K
EX-10.1
dltugizmc
17 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
erenlno22o4l3oze
13 May 16
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.2
whe6315l
31 Dec 15
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
z5qnhwd1va rnz6q70b
31 Dec 15
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.2
rzdr8
12 Nov 15
Relmada Therapeutics Strengthens its Board of Directors with the Appointment of Maged Shenouda and Paul Kelly
12:00am
8-K
EX-10.3
4ewwi4rs
12 Nov 15
Relmada Therapeutics Strengthens its Board of Directors with the Appointment of Maged Shenouda and Paul Kelly
12:00am
8-K
EX-10.4
4e4dsim3 bn6hr
12 Nov 15
Relmada Therapeutics Strengthens its Board of Directors with the Appointment of Maged Shenouda and Paul Kelly
12:00am
8-K
EX-10.1
o68xi5q
12 Nov 15
Relmada Therapeutics Strengthens its Board of Directors with the Appointment of Maged Shenouda and Paul Kelly
12:00am
8-K
EX-10.1
7qpbh6qy988xno
7 Aug 15
Entry into a Material Definitive Agreement
12:00am